International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily

International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023

Published:2023-08-16 Issue:6 Volume:75 Page:1233-1318
ISSN:0031-6997
Container-title:Pharmacological Reviews
language:en
Short-container-title:Pharmacol Rev

Author:

Burris Thomas P.,de Vera Ian Mitchelle S.,Cote Isabelle,Flaveny Colin A.,Wanninayake Udayanga S.,Chatterjee Arindam,Walker John K.,Steinauer Nickolas,Zhang Jinsong,Coons Laurel A.,Korach Kenneth S.,Cain Derek W.,Hollenberg Anthony N.,Webb Paul,Forrest Douglas,Jetten Anton M.^ORCID,Edwards Dean P.,Grimm Sandra L.^ORCID,Hartig Sean,Lange Carol A.,Richer Jennifer K.,Sartorius Carol A.,Tetel Marc,Billon Cyrielle,Elgendy Bahaa,Hegazy Lamees,Griffett Kristine,Peinetti Nahuel,Burnstein Kerry L.,Hughes Travis S.,Sitaula Sadichha,Stayrook Keitch R.,Culver Alexander,Murray Meghan H.,Finck Brian N.,Cidlowski John A.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference1346 articles.

1. Structural determination of estrogen-related receptor γ in the presence of phenol derivative compounds

2. Post-translational modifications of the progesterone receptors

3. 24(S)-Hydroxycholesterol Participates in a Liver X Receptor-controlled Pathway in Astrocytes That Regulates Apolipoprotein E-mediated Cholesterol Efflux

4. Does Palmitoylation Target Estrogen Receptors to Plasma Membrane Caveolae?

5. Cholesterol and 25-Hydroxycholesterol Inhibit Activation of SREBPs by Different Mechanisms, Both Involving SCAP and Insigs

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central role of SUMOylation in the regulation of chromatin interactions and transcriptional outputs of the androgen receptor in prostate cancer cells;Nucleic Acids Research;2024-08-06

2. Investigating REV-ERBβ Binding Pocket Dynamics with Implications for Rational Design of Small Molecule Modulators;2024-04-15

3. Mechanism of antagonist ligand binding to REV-ERBα;Scientific Reports;2024-04-10

4. EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells;Cellular and Molecular Life Sciences;2024-04-02

5. Structural Perspective of NR4A Nuclear Receptor Family and Their Potential Endogenous Ligands;Biological and Pharmaceutical Bulletin;2024-03-01